Response to letter to the editor OSIN-D-20-00441 re: "Denosumab-induced hypocalcemia in patients with osteoporosis: can you know who will get low?"

Osteoporos Int. 2020 Aug;31(8):1599. doi: 10.1007/s00198-020-05492-z. Epub 2020 Jun 12.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Bone Density Conservation Agents* / adverse effects
  • Denosumab / adverse effects
  • Humans
  • Hypocalcemia* / chemically induced
  • Osteoporosis* / chemically induced
  • Osteoporosis* / drug therapy

Substances

  • Bone Density Conservation Agents
  • Denosumab